» Articles » PMID: 36501070

The Impacts of Combined Blood Flow Restriction Training and Betaine Supplementation on One-Leg Press Muscular Endurance, Exercise-Associated Lactate Concentrations, Serum Metabolic Biomarkers, and Hypoxia-Inducible Factor-1α Gene Expression

Overview
Journal Nutrients
Date 2022 Dec 11
PMID 36501070
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this investigation was to compare the impacts of a potential blood flow restriction (BFR)-betaine synergy on one-leg press performance, lactate concentrations, and exercise-associated biomarkers. Eighteen recreationally trained males (25 ± 5 y) were randomized to supplement 6 g/day of either betaine anhydrous (BET) or cellulose placebo (PLA) for 14 days. Subsequently, subjects performed four standardized sets of one-leg press and two additional sets to muscular failure on both legs (BFR [LL-BFR; 20% 1RM at 80% arterial occlusion pressure] and high-load [HL; 70% 1RM]). Toe-tip lactate concentrations were sampled before (PRE), as well as immediately (POST0), 30 min (POST30M), and 3 h (POST3H) post-exercise. Serum homocysteine (HCY), growth hormone (GH) and insulin-like growth factor-1 concentrations were additionally assessed at PRE and POST30M. Analysis failed to detect any significant between-supplement differences for total repetitions completed. Baseline lactate changes (∆) were significantly elevated from POST0 to POST30 and from POST30 to POST3H (p < 0.05), whereby HL additionally demonstrated significantly higher ∆Lactate versus LL-BFR (p < 0.001) at POST3H. Although serum ∆GH was not significantly impacted by supplement or condition, serum ∆IGF-1 was significantly (p = 0.042) higher in BET versus PLA and serum ∆HCY was greater in HL relative to LL-BFR (p = 0.044). Although these data fail to support a BFR-betaine synergy, they otherwise support betaine’s anabolic potential.

Citing Articles

Editorial: Sports nutrition: muscle adaptation via supplementation and other nutritional strategies.

Harris D, Cardaci T, Ismaeel A, Church D, Heileson J, Machek S Front Nutr. 2025; 11:1539316.

PMID: 39749352 PMC: 11694595. DOI: 10.3389/fnut.2024.1539316.


Why blood flow restriction cuff features are an important methodological consideration- a short commentary on "cerebral cortex activation and functional connectivity during low-load resistance training with blood flow restriction: an fNIRS study".

Rolnick N, Clarkson M, Hughes L, Korakakis V, Queiros V, Patterson S Front Physiol. 2024; 15:1482816.

PMID: 39697617 PMC: 11652473. DOI: 10.3389/fphys.2024.1482816.


Unpacking the blood flow restriction device features literature: multi-chambered bladder design.

Rolnick N Front Sports Act Living. 2024; 6:1457539.

PMID: 39450118 PMC: 11499112. DOI: 10.3389/fspor.2024.1457539.


Making the case for prophylactic use of betaine to promote brain health in young (15-24 year old) athletes at risk for concussion.

Knight L, Knight T Front Neurosci. 2023; 17:1214976.

PMID: 37811321 PMC: 10556504. DOI: 10.3389/fnins.2023.1214976.


Beneath the cuff: Often overlooked and under-reported blood flow restriction device features and their potential impact on practice-A review of the current state of the research.

Rolnick N, Kimbrell K, Queiros V Front Physiol. 2023; 14:1089065.

PMID: 37064884 PMC: 10099250. DOI: 10.3389/fphys.2023.1089065.

References
1.
Loenneke J, Fahs C, Rossow L, Abe T, Bemben M . The anabolic benefits of venous blood flow restriction training may be induced by muscle cell swelling. Med Hypotheses. 2011; 78(1):151-4. DOI: 10.1016/j.mehy.2011.10.014. View

2.
Clow K, Treberg J, Brosnan M, Brosnan J . Elevated tissue betaine contents in developing rats are due to dietary betaine, not to synthesis. J Nutr. 2008; 138(9):1641-6. DOI: 10.1093/jn/138.9.1641. View

3.
Mahmoodi N, Harijan R, Schramm V . Transition-State Analogues of Phenylethanolamine -Methyltransferase. J Am Chem Soc. 2020; 142(33):14222-14233. PMC: 7558223. DOI: 10.1021/jacs.0c05446. View

4.
Veeranki S, Tyagi S . Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. Int J Mol Sci. 2013; 14(7):15074-91. PMC: 3742288. DOI: 10.3390/ijms140715074. View

5.
OConnor K, Stip E, Pelissier M, Aardema F, Guay S, Gaudette G . Treating delusional disorder: a comparison of cognitive-behavioural therapy and attention placebo control. Can J Psychiatry. 2007; 52(3):182-90. DOI: 10.1177/070674370705200310. View